On the afternoon of February 17, in the afternoon, Tencent and Skyworth and other giants gathered in Shenzhen Shennan Avenue, the headquarters of Mindray headquarters building, the reporter encountered the chairman of Mindray Li Xiting. After a black RV stopped, Li Xiting, the Chinese medical tycoon, came down from the car, his skin was dark, his dress was simple, and he carried a shoulder bag. The security personnel immediately opened the gates and elevator doors to welcome them.
Shenzhen Mindray Biomedical Electronics Co., Ltd. (hereinafter referred to as “ Mairui Medical †or “Miraiâ€) was founded in 1991 and landed in the US New York Stock Exchange in 2006. After 25 years of development, Mindray's product sales have expanded to more than 190 worldwide. Country and region. In 2015, international market sales accounted for 53% of operating income.
Since the privatization of Mindray in March 2016, the IPO process of this giant medical company has always touched the market. On February 7, the website of Shenzhen Securities Regulatory Bureau disclosed the announcement of Bank of China International Securities Co., Ltd. (hereinafter referred to as “BOC International Securitiesâ€) and Huatai United Securities Co., Ltd. (hereinafter referred to as “Huatai United Securitiesâ€) regarding the registration of Mindray Medical Counseling. Description. This means that Li Xiting will lead his Mindray Medical Industry Kingdom to formally compete in the A-share capital market.
Li Xiting hopes that Mindray can gain more value recognition and higher corporate status. Less than one year after the withdrawal from the US, Li Xiting made major adjustments to Mindray's corporate structure and shareholding ratio, and new investors entered the strength of Mindray. The entrepreneurial elders and backbones who played with Jiang Xiting together with Li Xiting also lurked in the shareholding structure and planned to share the feast of listing.
In the fiercely competitive Chinese market of multinational medical giants such as Siemens, Medtronic and GE, Mindray has tried its best. After the listing, increase the ability of technology research and development and innovation, and establish and consolidate its own advantages in marketing, after-sales service, etc. This is probably the goal that Li Xiting will pursue in the future.
IPO or wait a year and a half
With overseas listing and product cultivation, Mindray built the headquarters building of the main building plus the podium building five years ago. The company's core R&D department and important business department are gathered here.
Mindray Medical is China's largest and world's leading provider of medical devices and solutions. The company's products cover three areas: life information and support, in vitro diagnostics and medical imaging. In addition to its Shenzhen headquarters, Mindray has subsidiaries in North America, Europe, Asia, Africa, Latin America and other regions, forming a large global network of R&D, marketing and services.
Unlike most low-end medical device devices such as electronic sphygmomanometers , which are common medical companies in China, Mindray Medical is the only company that can compete with international giants in multiple categories and break the monopoly of multinational corporations.
Medical protective clothing refers to the protective clothing used by medical personnel (doctors, nurses, public health personnel, cleaning personnel, etc.) and people entering specific medical and health areas (such as patients, hospital visitors, personnel entering infected areas, etc.). Its function is to isolate germs, harmful ultrafine dust, acid and alkaline solutions, electromagnetic radiation, etc., to ensure the safety of personnel and keep the environment clean.
protective clothing,personal protection,disposable surgical protective clothing
Shanghai Rocatti Biotechnology Co.,Ltd , https://www.ljdmedicals.com